Market Access Insights

Early Access to Medicine Scheme Up and Running

Dr Steven Bradshaw & Dr David Carr
Posted: 05/06/2015

Since the program's launch in April 2014, three 'promising innovative medicine' (PIM) designations have already been granted as part of the UK's Early Access to Medicines Scheme (EAMS). The venture, from the UK's Medicines and Healthcare Products Regulatory Agency (MHRA), is aimed to speed up access to as yet unlicensed

To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

Dr Steven Bradshaw & Dr David Carr
Posted: 05/06/2015


Crowne Plaza Zurich, Zurich, Switzerland
June 17 - 19, 2018